Biotech News

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results

Intuitive (ISRG)Intuitive2026-06-25 13:46 ESTEarnings

SUNNYVALE, Calif. , Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead

Open original release

Related news

Intuitive

Intuitive is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States